Integra® Flowable Wound Matrix
Solution for Use in Deep Soft Tissue or Tunneling Wounds
The INTEGRA® Flowable Wound Matrix is an advanced wound care matrix comprised of a granulated cross-linked bovine tendon collagen and glycosaminoglycan. The granulated
collagen-glycosaminoglycan is hydrated with saline and applied in difficult to access wound sites and tunneled wounds. It provides a scaffold for cellular invasion and capillary growth.
The INTEGRA® Flowable Wound Matrix is mixed with sterile saline solution at the time of application to form a gel-like consistency. This flowable wound matrix is designed for use in deep soft tissue or tunneling wounds, such as diabetic ulcers, pressure ulcers, venous ulcers, chronic vascular ulcers and other wounds where a flowable wound matrix is appropriate.
When a wound is found to “tunnel” into deep soft tissue and has an irregular geometry, grafting with a sheet form is not adequate. In order to effectively correct the defect, one must obtain contact with the wound bed and fill the wound.
This can be accomplished with the INTEGRA® Flowable Wound Matrix, which is administered through a syringe with a flexible injector. This composition and method of administration allows for complete coverage in deep creviced wounds in a minimally invasive manner.
Indications
INTEGRA® Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including :
- Surgical wounds (donor sites/grafts, post-Moh’s surgery, postlaser surgery, podiatric, wound dehiscence).
- Diabetic ulcers.
- Diabetic ulcers of both partial and full-thickness varieties.
The device is intended for one-time use.
Contraindications
This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. The device is not indicated for use in third degree burns.
Ordering Information
Reference Description Quantity FDR 301 Flowable Wound Matrix 1 Unit/Kit 3cc
Product Catalogues
| Reference | Description | Quantity |
|---|---|---|
| FDR 301 | Flowable Wound Matrix | 1 Unit/Kit 3cc |
Regulatory Information
Class III
Integra LifeSciences Corporation
311 Enterprise Drive
Plainsboro • NJ 08536 • USA
Integra LifeSciences Services (France)
Immeuble Sequoia 2 • 97 allée Alexandre Borodine
Parc technologique de la Porte des Alpes
69800 Saint Priest • FRANCE
Phone: +33 (0)4 37 47 59 00 • fax: +33 (0)4 37 47 59 30
integralife.eu
Legal information
Availability of these products might vary from a given country or region to another, as a result of specific local regulatory approval or clearance requirements for sale in such country or region.
• Consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions and instructions for use.
• Non contractual document. Integra reserves the right, without prior notice, to modify the products in order to improve their quality.
• Warning: Applicable laws restrict these products to sale by or on the order of a physician.
Please contact Integra customer service should you need any additional information on devices classification.Products mentioned in this document are CE class III devices. All the medical devices mentioned on this document are CE marked according to European council directive 93/42/EEC on medical devices and its relatives, unless specifically identified as “NOT CE MARKED”.
Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation in the United States and/or other countries ©2017 Integra LifeSciences Corporation. All rights reserved
Last modification date: 10/2017. 0829103-1-EN Document for use in Europe, Middle-East & Africa only.
For complete product information, please consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions, and instructions for use.
